ID: ALA1625192

Max Phase: Preclinical

Molecular Formula: C18H16N+

Molecular Weight: 246.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(C[n+]2cccc(-c3ccccc3)c2)cc1

Standard InChI:  InChI=1S/C18H16N/c1-3-8-16(9-4-1)14-19-13-7-12-18(15-19)17-10-5-2-6-11-17/h1-13,15H,14H2/q+1

Standard InChI Key:  VRBJMGMJPXCJSU-UHFFFAOYSA-N

Associated Targets(Human)

Solute carrier family 22 member 1 646 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.33Molecular Weight (Monoisotopic): 246.1277AlogP: 3.69#Rotatable Bonds: 3
Polar Surface Area: 3.88Molecular Species: NEUTRALHBA: 0HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 0.18CX LogD: 0.18
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.62Np Likeness Score: -0.30

References

1. Bednarczyk D, Ekins S, Wikel JH, Wright SH..  (2003)  Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.,  63  (1): [PMID:12606755] [10.1124/mol.63.3.489]